EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral Lysozyme Attenuates Neuroinflammation and Brain Injury After Traumatic Brain Injury Through Gut Microbiota‐Dependent Reprogramming of Tryptophan Metabolism

Zhuoying Du, Haijun Yao, Caihua Xi, Qiang Yuan, Pengfei Fu, Jin Hu, Gang Wu, Weijian Yang iD

CNS Neuroscience & Therapeutics · 2026-07 · 32 (7)

DOI: 10.1002/cns.71025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 10.07.2026. Verfasst von Zhuoying Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Tryptophan, Muramidase, Brain Injuries, Traumatic, Gastrointestinal Microbiome. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research Foundation of Huashan Hospital, Affiliated to Fudan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Traumatic brain injury (TBI) induces secondary neuroinflammation and gut dysbiosis. This study investigated whether oral lysozyme confers neuroprotection after TBI through gut microbiota‐dependent metabolic reprogramming of tryptophan metabolism.

Methods

In a severe TBI mouse model, neurological function, neuroinflammation, intestinal barrier integrity, and systemic immune homeostasis were assessed following oral lysozyme administration. Fecal untargeted metabolomics, antibiotic‐mediated microbiota depletion, and fecal microbiota transplantation (FMT) were used to explore microbiota involvement. Cerebrospinal fluid (CSF) from 10 matched pairs of patients with severe TBI was analyzed for tryptophan pathway metabolites by liquid chromatography–mass spectrometry.

Results

Lysozyme improved neurological outcomes, attenuated neuronal apoptosis and neuroinflammation, and restored peripheral CD4 + /CD8 + T cell homeostasis. Metabolomics revealed enrichment of fecal tryptophan metabolites (indole‐3‐carboxaldehyde, indolelactic acid, kynurenic acid [KYNA]) and a shift in cerebral kynurenine metabolism toward the KYNA branch. These associations were abolished by microbiota depletion and reproduced by FMT. Favorable clinical outcomes were associated with higher CSF KYNA and an elevated KYNA/QA ratio.

Conclusions

Oral lysozyme was associated with attenuated TBI‐induced neuroinflammation and brain injury, potentially through gut microbiota‐dependent tryptophan metabolism reprogramming. Concordance between preclinical and clinical metabolomic data supports lysozyme as a candidate microbiota‐targeted therapeutic strategy. The KYNA/QA ratio warrants further validation as a prognostic indicator in larger, longitudinal cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TryptophanMuramidaseBrain Injuries, TraumaticGastrointestinal MicrobiomeNeuroinflammatory DiseasesNeuroprotective AgentsAnimalsMaleAdministration, OralMiceHumansMice, Inbred C57BL

Stichwörter der Autor:innen

gut–brain axiskynurenic acidlysozymeneuroinflammationtraumatic brain injurytryptophan metabolism

Substanzen

TryptophanMuramidaseNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • National Center for Neurological Disorders, Shanghai, China.
  • Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai, China.
  • Neurosurgical Institute of Fudan University, Shanghai, China.
  • Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China.
  • Department of Neurosurgery and Neurocritical Care, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.

ORCID-Profile: Weijian Yang

Förderung

  • National Natural Science Foundation of China
  • Research Foundation of Huashan Hospital, Affiliated to Fudan University

Zitieren

APA

Du, Z., Yao, H., Xi, C., Yuan, Q., Fu, P., Hu, J., Wu, G., & Yang, W. (2026). Oral Lysozyme Attenuates Neuroinflammation and Brain Injury After Traumatic Brain Injury Through Gut Microbiota‐Dependent Reprogramming of Tryptophan Metabolism. CNS Neuroscience & Therapeutics, 32(7). https://doi.org/10.1002/cns.71025

Vancouver

Du Z, Yao H, Xi C, Yuan Q, Fu P, Hu J, et al. Oral Lysozyme Attenuates Neuroinflammation and Brain Injury After Traumatic Brain Injury Through Gut Microbiota‐Dependent Reprogramming of Tryptophan Metabolism. CNS Neuroscience & Therapeutics. 2026;32(7). doi:10.1002/cns.71025

BibTeX
@article{Du2026,
  author = {Du, Zhuoying and Yao, Haijun and Xi, Caihua and Yuan, Qiang and Fu, Pengfei and Hu, Jin and Wu, Gang and Yang, Weijian},
  title = {Oral Lysozyme Attenuates Neuroinflammation and Brain Injury After Traumatic Brain Injury Through Gut Microbiota‐Dependent Reprogramming of Tryptophan Metabolism},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {7},
  doi = {10.1002/cns.71025}
}
Kostenlos starten →